Filing Details
- Accession Number:
- 0000899243-19-006340
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-05 21:09:18
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-05 21:09:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1351288 | Gw Pharmaceuticals Plc | GWPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754153 | Cabot Brown | Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-03-01 | 14,479 | $0.00 | 21,679 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-03-01 | 34,061 | $5.06 | 55,740 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-03-01 | 13,260 | $14.29 | 42,480 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2019-03-01 | 35,280 | $14.42 | 7,200 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2019-03-01 | 3,564 | $14.26 | 3,636 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Options | Disposition | 2019-03-01 | 14,479 | $0.00 | 14,479 | $0.00 |
| Ordinary Shares | Stock Options | Disposition | 2019-03-01 | 34,061 | $0.00 | 34,061 | $5.06 |
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 16,548 | $0.00 | 16,548 | $14.33 |
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 3,144 | $0.00 | 3,144 | $0.00 |
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 3,144 | $0.00 | 3,144 | $0.00 |
| Ordinary Shares | Stock Options | Acquisiton | 2019-03-01 | 3,144 | $0.00 | 3,144 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-12-29 | 2025-12-29 | No | 4 | M | Direct |
| 0 | 2018-12-29 | 2025-12-29 | No | 4 | M | Direct |
| 16,548 | 2022-03-01 | 2029-03-01 | No | 4 | A | Direct |
| 3,144 | 2020-03-01 | No | 4 | A | Direct | |
| 3,144 | 2021-03-01 | No | 4 | A | Direct | |
| 3,144 | 2022-03-01 | No | 4 | A | Direct |
Footnotes
- Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019.
- These ordinary shares are represented by ADSs.
- The price reported in Column 4 is a weighted average price per ordinary share ($171.52 per ADS). These shares were sold in multiple transactions at prices ranging from $171.23 per ADS (or 14.27 per ordinary share) to $171.94 per ADS (or $14.33 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price per ordinary share ($172.98 per ADS). These shares were sold in multiple transactions at prices ranging from $172.38 per ADS (or 14.37 per ordinary share) to $173.30 per ADS (or $14.44 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price per ordinary share ($171.16 per ADS). These shares were sold in multiple transactions at prices ranging from $171.14 per ADS (or 14.26 per ordinary share) to $171.18 per ADS (or $14.26 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Granted pursuant to the Issuer's Long-Term Incentive Plan
- The reported options are options to purchase ADSs.
- The exercise price reported is price per ordinary share converted from price per ADS ($172.01).
- These stock options will vest automatically on exercisable date.
Billionaire Hedge Funds
